Literature DB >> 34280291

Review of Existing Models to Predict Reductions in Neural Tube Defects Due to Folic Acid Fortification and Model Results Using Data from Cameroon.

Hanqi Luo1,2,3, Kenneth H Brown1,2, Christine P Stewart1,2, Laurel A Beckett4, Adrienne Clermont5, Stephen A Vosti6, Jules M Guintang Assiene7, Reina Engle-Stone1,2.   

Abstract

Several models have been developed to predict the effects of folic acid fortification programs on prevention of neural tube defects (NTDs), but each relies on different assumptions and data inputs. We identified and reviewed 7 models that predict the effects of folic acid intake or status on NTD risk. We applied 4 of these models [the original and a modified version of the Lives Saved Tool (LiST) and models developed by Arth et al. and Wald et al.] to predict the effect of folic acid fortification of wheat flour on reduction of NTDs using national survey data from Cameroon. The estimated percentage of NTDs averted due to fortified wheat flour (5.0 μg folic acid/g flour) varied by predictive model, with a 21-31% reduction in LiST to 83% in Arth's model, and 15% in Wald's model. As the simulated fortification level was increased from 1.0 to 7.0 μg folic acid/g flour, the pattern of change in estimated numbers of NTDs averted differed due to different model assumptions: the number of NTDs averted increased and then reached a plateau in the modified LiST model (as would be expected in real-world conditions), increased sharply in Arth's model, and increased continuously in Wald's model. This wide variation in predicted effects, and implausible results in some cases, undermines the models' utility for users of model outputs. Concurrent collection of dietary and biomarker data, including plasma and RBC folate concentrations, and NTD outcomes, is necessary to validate these models and monitor change in folic acid intake, folate-related biomarkers, and reduced NTD risk due to fortification. In the meantime, models based on erythrocyte folate concentration are recommended, based on biological plausibility and consistency with empirical evidence. Where erythrocyte folate data are unavailable, sensitivity analyses (using several models) could be conducted to examine the range of possible outcomes.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  Cameroon; folic acid; fortification; neural tube defects; nutritional models

Mesh:

Substances:

Year:  2021        PMID: 34280291      PMCID: PMC8634386          DOI: 10.1093/advances/nmab083

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   8.701


  34 in total

1.  A 2015 global update on folic acid-preventable spina bifida and anencephaly.

Authors:  Annelise Arth; Vijaya Kancherla; Helena Pachón; Sarah Zimmerman; Quentin Johnson; Godfrey P Oakley
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-07

2.  Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; William R Phillips; Maureen G Phipps; Michael P Pignone; Michael Silverstein; Chien-Wen Tseng
Journal:  JAMA       Date:  2017-01-10       Impact factor: 56.272

3.  Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis.

Authors:  Hannah Blencowe; Vijaya Kancherla; Sowmiya Moorthie; Matthew W Darlison; Bernadette Modell
Journal:  Ann N Y Acad Sci       Date:  2018-01-24       Impact factor: 5.691

Review 4.  Historical perspective on folic acid and challenges in estimating global prevalence of neural tube defects.

Authors:  Vijaya Kancherla; Robert E Black
Journal:  Ann N Y Acad Sci       Date:  2018-02       Impact factor: 5.691

5.  Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention.

Authors:  R J Berry; Z Li; J D Erickson; S Li; C A Moore; H Wang; J Mulinare; P Zhao; L Y Wong; J Gindler; S X Hong; A Correa
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

6.  Folate status and homocysteine response to folic acid doses and withdrawal among young Chinese women in a large-scale randomized double-blind trial.

Authors:  Ling Hao; Quan-He Yang; Zhu Li; Lynn B Bailey; Jiang-Hui Zhu; Dale J Hu; Bo-Lan Zhang; J David Erickson; Le Zhang; Jacqueline Gindler; Song Li; Robert J Berry
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

7.  Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects.

Authors:  P N Kirke; A M Molloy; L E Daly; H Burke; D G Weir; J M Scott
Journal:  Q J Med       Date:  1993-11

8.  Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects: World Health Organization guidelines.

Authors:  Amy M Cordero; Krista S Crider; Lisa M Rogers; Michael J Cannon; R J Berry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-04-24       Impact factor: 17.586

9.  Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model.

Authors:  Krista S Crider; Owen Devine; Ling Hao; Nicole F Dowling; Song Li; Anne M Molloy; Zhu Li; Jianghui Zhu; Robert J Berry
Journal:  BMJ       Date:  2014-07-29

10.  Systematic Review and Bayesian Meta-analysis of the Dose-response Relationship between Folic Acid Intake and Changes in Blood Folate Concentrations.

Authors:  Krista S Crider; Owen Devine; Yan Ping Qi; Lorraine F Yeung; Ahlia Sekkarie; Ibrahim Zaganjor; Eugene Wong; Charles E Rose; Robert J Berry
Journal:  Nutrients       Date:  2019-01-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.